Valontan children 25 mg - against motion sickness 4 coated tablets

Product Description

Recordati

Prevention of Nausea, Seasickness, Car, Plane, Train; 4 Coated Tablets

Active ingredients

Coated tablets: Each coated tablet contains: Active ingredient Dimenhydrinate 25 mg

Excipients

Coated tablets: Each coated tablet contains: Excipients: Sucrose 15.0 mg, polyvinylpyrrolidone 2.0 mg, precipitated silica 1.5 mg, magnesium stearate 1.5 mg, maize starch 45.0 mg, hydroxypropylmethylcellulose 1.875 mg, polyethylene glycol 400 0.1875 mg, titanium dioxide 0.9375 mg.

Therapeutic indications

Prevention and treatment of nausea, vomiting, and dizziness typical of naupathies (seasickness, car sickness, train sickness, and airsickness).

Contraindications

Hypersensitivity to the active substance or to any of the excipients. Contraindicated in children under 2 years of age. Generally contraindicated during pregnancy and breastfeeding.

Dosage

In children aged 2-6 years: 1 tablet or 1 suppository of VALONTAN children up to a maximum of 3 times a day, as needed. In children aged 7-12 years: 1-2 tablets or suppositories of VALONTAN children 2-3 times a day. It is recommended to take it about 30 minutes before obtaining the desired effect. Do not administer to children under 2 years of age (see 4.3). Do not exceed the recommended doses. Do not use for prolonged treatments.

Warnings and precautions

The use of antihistamines simultaneously with certain antibiotics or other ototoxic drugs may mask the first signs of ototoxicity, which may only become apparent when the damage is irreversible. Use with caution in subjects suffering from glaucoma, prostatic hypertrophy, other urinary retention syndromes, intestinal obstruction, arterial hypertension, cardiovascular disease, bronchial asthma, chronic bronchitis or emphysema, hyperthyroidism. The medicine may exacerbate seizure disorders. It should therefore be used with great caution in subjects suffering from epilepsy. The tablets contain sucrose and are therefore not suitable for subjects with hereditary fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase deficiency.

Interactions

During treatment, in order to prevent additive sedation, the child should not be given drugs that act on the Central Nervous System.

Side effects

The most frequent side effect of antihistamines is sedation, which may manifest as drowsiness. Dry mouth, photosensitivity, accommodation disorders, urination disorders, headache, anorexia, nausea, and allergic skin reactions may occur with the use of antihistamines. Less frequently, dizziness, asthenia, insomnia (especially in children), euphoria, tremors, hypotension, tachycardia, and, at high doses, especially in children, convulsions.

Pregnancy and breastfeeding

Use during pregnancy is not recommended. In breastfeeding patients, it is necessary to decide whether to stop breastfeeding the child and start treatment or, vice versa, to continue breastfeeding while avoiding administration of the product.